STOCK TITAN

ANAB (NASDAQ: ANAB) files Form 144 for 2,017-share stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ANAB filed a Form 144 notice for a planned insider stock sale. The filing shows a planned sale of 2,017 shares of common stock through Morgan Stanley Smith Barney on the NASDAQ, with an aggregate market value of $88,566.47. The shares relate to restricted stock units acquired from the issuer on January 7, 2026 and paid for in cash. The filing lists 27,688,470 shares of the issuer’s common stock outstanding.

The notice also reports prior transactions by Eric J. Loumeau over the past three months, including sales such as 12,500 shares on December 16, 2025 for $560,800.25 and 10,000 shares on December 17, 2025 for $460,000. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows a modest, disclosed insider sale and recent selling activity.

This Form 144 indicates that an insider, Eric J. Loumeau, plans to sell 2,017 shares of common stock via Morgan Stanley on the NASDAQ. The shares come from restricted stock units acquired on January 7, 2026 and are valued at about $88,566.47 based on the filing.

The document also details several recent sales in the prior three months, including blocks of 12,500 and 10,000 shares with gross proceeds of $560,800.25 and $460,000, respectively. With 27,688,470 shares outstanding, these transactions represent a small fraction of total equity. The representation that the seller knows no undisclosed material adverse information is standard for this type of notice and does not, by itself, signal a change in the company’s fundamentals.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ANAB's latest Form 144 filing disclose?

The filing discloses that 2,017 shares of ANAB common stock are planned to be sold through Morgan Stanley Smith Barney on the NASDAQ, with an aggregate market value of $88,566.47.

Who is selling ANAB shares in this Form 144 and how were they acquired?

Eric J. Loumeau is the person for whose account the shares are to be sold. The 2,017 shares come from restricted stock units acquired from the issuer on January 7, 2026 and paid for in cash.

How many ANAB shares are outstanding according to this Form 144?

The Form 144 states that there are 27,688,470 shares of ANAB common stock outstanding.

What recent ANAB stock sales by Eric J. Loumeau are reported in the past 3 months?

The notice lists several sales, including 12,500 shares on December 16, 2025 for $560,800.25 and 10,000 shares on December 17, 2025 for $460,000, along with other smaller transactions.

What representation does the seller make in ANAB's Form 144?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

On which exchange are the ANAB shares in this Form 144 planned to be sold?

The Form 144 identifies the planned sales as occurring on the NASDAQ securities exchange.

Anaptysbio Inc

NASDAQ:ANAB

View ANAB Stock Overview

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.79B
27.07M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO